Abstract
Injectable polysaccharide microcapsules holding minocycline were fabricated from alginate and chitosan for the treatment of periodontitis. The microcapsules were examined for the release and degradation of minocycline, as well as antimicrobial activity. The microcapsules were biodegradable and released minocycline between 10 and 1000 μg ml-1, which was higher than the usual therapeutic concentration (1-5 μg ml-1), for up to 7 days. These microcapsules showed a statistically significant suppression of pathogenic bacteria, such as Prevotella intermedia causing periodontitis. The microcapsules are thus potentially useful for drug delivery for the treatment of periodontitis.
Original language | English |
---|---|
Pages (from-to) | 1761-1766 |
Number of pages | 6 |
Journal | Biotechnology Letters |
Volume | 27 |
Issue number | 22 |
DOIs | |
State | Published - Nov 2005 |
Bibliographical note
Funding Information:This research was supported by the grant from Korea Science and Engineering Foundation (KOSEF) through Intellectual Biointerface Engineering Center (IBEC) at Seoul National University, Korea.
Keywords
- Controlled release
- Injectable microcapsules
- Minocycline
- Periodontitis
- Polysaccharide